18F-FLT

What 18F-FLT Means in Everyday Medical Language

18F-FLT, also called 18F-fluorothymidine or 3’-deoxy-3’-(18F) fluorothymidine, is a special radioactive substance used in some cancer imaging tests. It is injected into a vein and travels through the bloodstream to collect in cells that are actively dividing. Since cancer cells tend to divide more quickly than normal cells, 18F-FLT tends to build up in tumors. As it breaks down, it emits a small amount of radiation that can be detected by a PET scan, creating detailed pictures of where cancer cells might be active.

Why 18F-FLT Can Matter in Cancer Care

This tracer is important because it helps doctors see areas of active cancer growth by focusing on cell division. Unlike other imaging agents that highlight general metabolism or sugar use, 18F-FLT specifically targets dividing cells, which may provide more specific information about how aggressive a tumor is or how it is responding to treatment. This can help doctors find tumors, understand how advanced the cancer is, and monitor treatment effects. However, 18F-FLT is still being studied and is not yet widely used in routine cancer care.

What Patients Might See or Hear About 18F-FLT

If your care team mentions 18F-FLT, it might be in the context of a clinical trial or a specialized imaging test. You may be told that the tracer will be injected before a PET scan, which will then show areas where the tracer has gathered. This can help highlight active cancer cells. It is important to know that not all areas with 18F-FLT uptake are definitely cancer, as some normal cells that divide frequently can also take up the tracer. Your doctors will interpret the scan results carefully along with other tests and information.

What 18F-FLT Does Not Automatically Mean

Seeing 18F-FLT mentioned does not mean a definitive cancer diagnosis has been made. The scan helps guide doctors by showing where cancer cells might be active, but it is not a standalone test and cannot replace biopsies or other diagnostic procedures. Some normal tissues that divide often may also show uptake, so results need careful interpretation. Because 18F-FLT is still under study, it may not be available everywhere or covered by insurance.

How Doctors Use 18F-FLT in Diagnosis and Monitoring

Doctors may use 18F-FLT PET scans to help find tumors, determine how far cancer has spread, monitor how well treatment is working, or check for cancer recurrence. By focusing on cell division, this tracer can sometimes provide more specific information about tumor activity than other imaging tests. It is usually part of a broader diagnostic approach rather than a single test.

Common Questions to Ask Your Care Team

If 18F-FLT imaging is recommended, you might ask why this tracer is being used instead of others, what the scan results might mean for your care, and whether the test is part of a research study. Understanding how this imaging fits into your overall diagnosis and treatment plan can help you feel more informed and involved.

Safety and Context

Because 18F-FLT is radioactive, it is used carefully and only when the potential benefits outweigh any risks. The amount of radiation is generally low and similar to other PET scan tracers. Your medical team will explain why this test is recommended and what to expect during the scan. This information is educational and does not replace personalized advice from your doctors.

Next Steps for Patients

If you hear about 18F-FLT during your cancer care, the best next step is to talk with your doctor or nurse about what the test involves, what to expect, and how the results might help guide your treatment. They can explain whether this imaging option fits your needs and answer any questions you have. Being informed about 18F-FLT can help you feel more confident and involved in your care decisions.